<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Prognostic value of nuclear morphometry in myxoid liposarcoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Prognostic value of nuclear morphometry in myxoid liposarcoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d6/10154898/09ac0432937f/CAS-114-2178-g004.jpg"/> </div> <div class="text-side"> <h1>Prognostic value of nuclear morphometry in myxoid liposarcoma.</h1> <p>Histology of myxoid liposarcoma (MLS), as assessed by the modified Fuhrman grading system in high‐power fields (HE; ×400). Grade 1 with small nuclei and no visible nucleoli (A). Grade 2 with slightly larger nuclei and visible nucleoli only in the high‐power field (HPF) (B). Grade 3 with larger nuclei and distinct nucleoli (C). Grade 2 in the modified World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading due to the hyperchromatic nuclei and no visible nucleoli in the ×100 magnification, but with larger and irregular‐shaped nuclei suggesting a modified Fuhrman grade 3 (D). Grade 4 with anaplastic tumor cells having significantly larger or extremely irregular‐shaped nuclei (E, F). The features are not assigned to “classical” RCC due to the lower cell density, although they qualify as high grade based on the modified Fuhrman and WHO/ISUP grading systems (C‐F)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36661410/" target="_blank">36661410</a></p><p>Type: Premalignant/Malignant, Category: Adipocytic</p>
</div> </div></div></body></html>